These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 29524506

  • 1. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
    Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, Reiter RE.
    J Urol; 2018 Sep; 200(3):564-572. PubMed ID: 29524506
    [Abstract] [Full Text] [Related]

  • 2. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE.
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30142318
    [Abstract] [Full Text] [Related]

  • 3. Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic Tests.
    Falagario UG, Beksac AT, Martini A, Cumarasamy S, Gupta A, Prasad S, Thulasidass H, Shah QN, Jayaratna I, Lewis S, Rastinehad AR, Taouli B, Cormio L, Carrieri G, Tewari AK.
    J Urol; 2019 Jul; 202(1):102-107. PubMed ID: 30730408
    [Abstract] [Full Text] [Related]

  • 4. Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies.
    Martin DT, Ghabili K, Levi A, Humphrey PA, Sprenkle PC.
    Urology; 2019 Mar; 125():64-72. PubMed ID: 30552940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN, Bloom JB, Gold SA, Hale GR, Baiocco JA, Mehralivand S, Czarniecki M, Sabarwal VK, Valera V, Wood BJ, Merino MJ, Choyke P, Turkbey B, Pinto PA.
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [Abstract] [Full Text] [Related]

  • 7. Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.
    Beksac AT, Cumarasamy S, Falagario U, Xu P, Takhar M, Alshalalfa M, Gupta A, Prasad S, Martini A, Thulasidass H, Rai R, Berger M, Hectors S, Jordan J, Davicioni E, Nair S, Haines K, Lewis S, Rastinehad A, Yadav K, Jayaratna I, Taouli B, Tewari A.
    J Urol; 2018 Dec; 200(6):1241-1249. PubMed ID: 30563651
    [Abstract] [Full Text] [Related]

  • 8. Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate.
    Ullrich T, Quentin M, Arsov C, Schmaltz AK, Tschischka A, Laqua N, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L.
    J Urol; 2018 Mar; 199(3):691-698. PubMed ID: 28941924
    [Abstract] [Full Text] [Related]

  • 9. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
    Radtke JP, Takhar M, Bonekamp D, Kesch C, Erho N, du Plessis M, Buerki C, Ong K, Davicioni E, Hohenfellner M, Hadaschik BA.
    Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction.
    Distler FA, Radtke JP, Bonekamp D, Kesch C, Schlemmer HP, Wieczorek K, Kirchner M, Pahernik S, Hohenfellner M, Hadaschik BA.
    J Urol; 2017 Sep; 198(3):575-582. PubMed ID: 28373135
    [Abstract] [Full Text] [Related]

  • 12. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham JA, Vargas HA, Coleman J, Ehdaie B.
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [Abstract] [Full Text] [Related]

  • 13. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S.
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [Abstract] [Full Text] [Related]

  • 14. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB, Lefèvre A, Bouazza N, Beuvon F, Legman P, Cornud F.
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial.
    Lovegrove CE, Miah S, El-Shater Bosaily A, Bott S, Brown L, Burns-Cox N, Dudderidge T, Freeman A, Henderson A, Hindley R, Kaplan R, Kirkham A, Oldroyd R, Parker C, Persad R, Punwani S, Rosario D, Shergill I, Winkler M, Emberton M, Ahmed HU.
    J Urol; 2020 Jan; 203(1):100-107. PubMed ID: 31335254
    [Abstract] [Full Text] [Related]

  • 16. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance.
    Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR.
    J Urol; 2019 Feb; 201(2):300-307. PubMed ID: 30179620
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA.
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?
    Lanz C, Cornud F, Beuvon F, Lefèvre A, Legmann P, Zerbib M, Delongchamps NB.
    J Urol; 2016 Jan; 195(1):88-93. PubMed ID: 26165586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.